Your browser doesn't support javascript.
loading
Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation.
Esler, Murray D; Osborn, John W; Schlaich, Markus P.
Afiliação
  • Esler MD; Human Neurotransmitter Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (M.D.E., M.P.S.).
  • Osborn JW; Department of Surgery, Medical School, University of Minnesota, Minneapolis (J.W.O.).
  • Schlaich MP; Human Neurotransmitter Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (M.D.E., M.P.S.).
Hypertension ; 81(6): 1194-1205, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38557153
ABSTRACT
The importance of the sympathetic nervous system in essential hypertension has been recognized in 2 eras. The first was in early decades of the 20th century, through to the 1960s. Here, the sympathetic nervous system was identified as a target for the treatment of hypertension, and an extensive range of antiadrenergic therapies were developed. Then, after a period of lapsed interest, in a second era from 1985 on, the development of precise measures of human sympathetic nerve firing and transmitter release allowed demonstration of the importance of neural mechanisms in the initiation and maintenance of the arterial blood pressure elevation in hypertension. This led to the development of a device treatment of hypertension, catheter-based renal denervation, which we will discuss.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simpatectomia / Sistema Nervoso Simpático / Hipertensão / Rim Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simpatectomia / Sistema Nervoso Simpático / Hipertensão / Rim Idioma: En Ano de publicação: 2024 Tipo de documento: Article